The Effect of Vitamin D Supplementation on Markers of Inflammation in High-Risk Cardiovascular Patients With Low Levels of Serum 25-Hydroxyvitamin D (VINCA-CKD)

NCT01012414 Phase 3 TERMINATED Results posted

The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.

Details

Lead sponsor	Thomas Jefferson University
Phase	Phase 3
Status	TERMINATED
Enrolment	10
Start date	2010-01
Completion	2011-05

Conditions

• Coronary Artery Disease
• Chronic Kidney Disease
• Hypovitaminosis D
• Secondary Hyperparathyroidism

Interventions

• paricalcitol
• placebo

Primary outcomes

• Change in High Sensitivity-C Reactive Protein (Serum) — 1 year

Countries

United States